Concerning trends and regional disparities for patients having lower limb amputations related to peripheral arterial disease, have been revealed in a new study. Amputation rates in the North of ...

This review examines the current guidance and issues related to lipid optimization of patients with peripheral arterial disease (PAD). A narrative review that was published in the Annals of Vascular ...

"It's important to recognize the signs and symptoms of PAD and move quickly to initiate treatment to improve outcomes and reduce risks." HealthDay News — In a clinical practice guideline issued by the ...

Extracorporeal shockwave therapy may be effective for intermittent lower limb claudication in peripheral artery disease (PAD) patients unable to engage in supervised exercise or who experienced little ...

In patients with peripheral artery disease undergoing revascularization, major adverse limb events were more common with ...

The angiotensin II receptor blocker (ARB) telmisartan (Micardis) did not significantly improve walking performance in patients with lower-extremity peripheral artery disease (PAD) in a randomized ...

Please provide your email address to receive an email when new articles are posted on . GLP-1s were linked to reduced risk for major adverse CV and limb events at 1 year in patients with moderate ...

A long-term analysis of French patients who received paclitaxel-coated balloons and stents for the management of peripheral artery disease (PAD) is adding more evidence to refute the existence of a ...

Disparities in rates of peripheral diabetic neuropathy and lower extremity amputation exist in the United States. To investigate the factors linked to this disparity, we performed a systematic review ...

A USC study finds immunotherapy increases PAD risk by 60%. Experts advise vascular monitoring to help prevent limb loss in ...